<DOC>
	<DOCNO>NCT00846274</DOCNO>
	<brief_summary>To evaluate PK/PD single inject human ATIII Products , SKATIII ATIII , phase1 study healthy male subject design</brief_summary>
	<brief_title>Phase1 Syudy Evaluate Safety PK/PD Human Antithrombin III</brief_title>
	<detailed_description />
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>age 19 40 Body weight : More 50kg Healthy male subject Hb &lt; 14g/dL , Hct &lt; 42 % ATIII hypersensitivity</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Healthy Male subject</keyword>
</DOC>